Cargando…
A phase II study of raltitrexed and gemcitabine in patients with advanced pancreatic carcinoma
Advanced adenocarcinoma of the pancreas has a very poor prognosis. The aim of this study was to assess the efficacy and tolerability of a combination of the chemotherapeutic agents gemcitabine and raltitrexed. Chemonaïve patients with advanced adenocarcinoma of the pancreas were treated with a combi...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362068/ https://www.ncbi.nlm.nih.gov/pubmed/15668704 http://dx.doi.org/10.1038/sj.bjc.6602368 |